Prospective, Multi-center Study to Assess Posterolateral Fusion Using FIBERGRAFT
A Post-market, Prospective, Multi-center, Nonrandomized Study to Assess Posterolateral Lumbar Fusions Using FIBERGRAFT BG Matrix
Sponsor: Prosidyan, Inc.
This NA trial investigates Degenerative Disc Disease and Spinal Stenosis Lumbar and is currently completed. Prosidyan, Inc. leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2024 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Jan 2023 — May 2024 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — Jan 2023 [monthly]
Enrolling By Invitation NA
▶ Show 3 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
Phase: PHASE3 → NA
-
Feb 2020 — Sep 2020 [monthly]
Enrolling By Invitation PHASE3
-
Apr 2019 — Feb 2020 [monthly]
Enrolling By Invitation PHASE3
First recorded
Feb 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Prosidyan, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .